## Rollout `base1`
- outcome: submitted
- turns: 4; cost: $0.142; submitted: True

### Turn 1  (stop_reason=tool_use)
- web_search(query="Snap Inc 2024 annual report convertible senior notes maximum shares issuable") → 0 results: 
- edgar_search({"search_query": "Snap Inc convertible notes dilutive shares December 31, 2024", "start_date": "2025-01-01", "end_date": "2025-04-07"})
  result: {"total_matching_documents": 110, "page": 1, "results": [{"form": "10-K", "file_date": "2025-02-05", "period_ending": "2024-12-31", "company": "Snap Inc  (SNAP)  (CIK 0001564408)", "ciks": ["0001564408"], "accession": "0001564408-25-000019", "document": "snap-20241231.htm", "description": "10-K", "url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm"}, {"form": "S-1/A", "file_date": "2025-04-04", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002278", "document": "coeptis-s1a2.htm", "description": "AMENDMENT #2 TO FORM S-1", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825002278/coeptis-s1a2.htm"}, {"form": "424B3", "file_date": "2025-04-02", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002228", "document": "coeptis_424b3-333269782.htm", "description": "PROSPECTUS", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825002228/coeptis_424b3-333269782.htm"}, {"form": "10-K", "file_date": "2025-03-28", "period_ending": "2024-12-31", "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-001942", "document": "coeptis_i10k-123124.htm", "description": "FORM 10-K FOR DEC 2024", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825001942/coeptis_i10k-123124.htm"}, {"form": "424B3", "file_date": "2025-04-02", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002229", "document": "coeptis_
  …[truncated 5,599 chars]

### Turn 2  (stop_reason=tool_use)
- web_search(query=null) → 9 results: Snap Inc - Form 10-K - FY2024 <https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm>; Snap Inc - Form 10-Q - FY2024 <https://www.sec.gov/Archives/edgar/data/1564408/000156440824000050/snap-20240630.htm>; Snap Inc - Form 10-Q - FY2024 <https://www.sec.gov/Archives/edgar/data/1564408/000156440824000034/snap-20240331.htm>; Snap Inc - Form 10-Q - FY2024 <https://www.sec.gov/Archives/edgar/data/1564408/000156440824000062/snap-20240930.htm>; Snap Inc (Form: 8-K, Received: 05/13/2024 17:00:08) <https://content.edgar-online.com/ExternalLink/EDGAR/0001193125-24-137315.html?hash=70016b92508d2ab764b42cbe1d084ceae1988ac2b51d443cf00c2dec7f7d2914&dest=d821313dex41_htm>
- parse_html_page({"url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm", "key": "snap10k"})
  result: SUCCESS: The result has been saved to the data storage under the key: snap10k. (614,017 characters)
  The data_storage currently contains the following keys:
  snap10k
  

### Turn 3  (stop_reason=tool_use)
- retrieve_information({"prompt": "From this Snap Inc 10-K text: {{snap10k}}, find the net income per share note's table of potentially dilutive securities excluded from diluted net income (loss) per share as of December 31, 2024. Report the convertible notes rows (2025 Notes, 2026 Notes, 2027 Notes, 2028 Notes, 2030 Notes, total) with exact share numbers, and any text describing the maximum shares issuable upon conversion, capped calls, or the treatment of convertible notes in the diluted EPS calculation. Quote the relevant sentences."})
  result: The Note 3 table does not break out the convertible notes by series. It reports a single line, "Convertible Notes (if-converted)," with 85,945 thousand shares as of December 31, 2024:
  
  | As of December 31, 2024 | Shares (in thousands) |
  |---|---|
  | Stock options | 680 |
  | Unvested RSUs and RSAs | 134,253 |
  | Convertible Notes (if-converted) | 85,945 |
  
  The filing gives no per-note share counts in that table. Using the conversion rates and principal amounts from Note 7, I calculated the approximate share count for each series. These figures are my derivation, not disclosed numbers, but they sum to the reported total:
  
  | Series | Principal ($ millions) | Conversion rate (shares per $1,000) | Implied shares (millions) |
  |---|---|---|---|
  | 2025 Notes | 36.2 | 46.1233 | ~1.67 |
  | 2026 Notes | 249.8 | 43.8481 | ~10.95 |
  | 2027 Notes | 1,150.0 | 11.2042 | ~12.89 |
  | 2028 Notes | 1,500.0 | 17.7494 | ~26.62 |
  | 2030 Notes | 750.0 | 45.0846 | ~33.81 |
  | **Total** | **3,686.0** | | **~85.9** |
  
  **Relevant text from the filing**
  
  Note 3 (Net Loss per Share):
  - "We use the if-converted method for calculating any potential dilutive effect of the convertible senior notes due in 2025, 2026, 2027, 2028, and 2030 (collectively, the 'Convertible Notes') on diluted net loss per share. The Convertible Notes would have a dilutive impact on net income per share when the average market price of Class A common stock for a given period exceeds the respective conversion price of the Convertible Notes."
  - "For the periods presented, our potentially dilutive shares relating to stock options, RSUs, RSAs, and Convertible Notes were not included in the computation of diluted net loss per share as the effect of including these shares in the calculation would have been anti-dilutive."
  
  Note 7 (Debt), o
  …[truncated 1,304 chars]

### Turn 4  (stop_reason=tool_use)
- submit_final_result({"final_result": "**Answer: about 85.945 million shares (85,945 thousand) is the maximum dilutive impact of Snap's convertible notes as of December 31, 2024, on an if-converted basis.**\n\n**How I got there**\n\n1. Snap's FY2024 10-K (filed February 5, 2025) covers the convertible notes due 2025, 2026, 2027, 2028 and 2030. Its net loss per share note says Snap uses the if-converted method for these notes, and that potentially dilutive shares from options, RSUs, RSAs and the convertible notes were excluded from diluted loss per share because they were anti-dilutive.\n2. The note's table of potentially dilutive securities, as of December 31, 2024, lists stock options at 680 thousand, unvested 
…[truncated 2,183 chars])

### Final answer
**Answer: about 85.945 million shares (85,945 thousand) is the maximum dilutive impact of Snap's convertible notes as of December 31, 2024, on an if-converted basis.**

**How I got there**

1. Snap's FY2024 10-K (filed February 5, 2025) covers the convertible notes due 2025, 2026, 2027, 2028 and 2030. Its net loss per share note says Snap uses the if-converted method for these notes, and that potentially dilutive shares from options, RSUs, RSAs and the convertible notes were excluded from diluted loss per share because they were anti-dilutive.
2. The note's table of potentially dilutive securities, as of December 31, 2024, lists stock options at 680 thousand, unvested RSUs and RSAs at 134,253 thousand, and "Convertible Notes (if-converted)" at 85,945 thousand. The convertible notes figure is the only one relevant to your question, and the table does not break it out by series.
3. Per-series figures are not disclosed. They are my derivation from the principal outstanding and conversion rates in the debt note (Note 7), and they reconcile to the reported total:

| Series | Principal outstanding ($M) | Conversion rate (shares per $1,000) | Implied shares (M) |
|---|---|---|---|
| 2025 Notes | 36.2 | 46.1233 | ~1.67 |
| 2026 Notes | 249.8 | 43.8481 | ~10.95 |
| 2027 Notes | 1,150.0 | 11.2042 | ~12.89 |
| 2028 Notes | 1,500.0 | 17.7494 | ~26.62 |
| 2030 Notes | 750.0 | 45.0846 | ~33.81 |
| Total | | | ~85.94 |

The 2026 principal of $249.8M was taken from the stored filing text and was not independently confirmed; the other principal amounts were confirmed in the 10-K's liquidity discussion. The per-series split is approximate, but the total of 85,945 thousand shares is the disclosed figure.

**Context**

- Snap reported a net loss for the period, so the notes were anti-dilutive and excluded from diluted EPS. The 85.9 million shares is the maximum potential dilution, not an amount included in reported diluted EPS.
- The notes are settled in cash, shares, or a combination at Snap's election. The company also entered into capped call transactions, which are meant to reduce dilution up to the cap prices. The EPS note does not say whether the capped calls are reflected in the diluted share count.
- As of December 31, 2024, the if-converted value of the notes did not exceed their principal amount.

**Sources**
{
    "sources": [
        {
            "url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm",
            "name": "Snap Inc. Form 10-K for fiscal year 2024 (filed 2025-02-05)"
        },
        {
            "url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440824000058/snap-20241029xexx991pressr.htm",
            "name": "Snap Inc. Q3 2024 earnings press release (balance sheet reference)"
        }
    ]
}